(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Day One Biopharmaceuticals, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, April 11th, 2025 | 2023 | Jeremy Bender Chief Executive Officer and President | 647,000 | 0 | 1,779,160 | 388,200 | 13,200 | 6,913,959 |
| Friday, April 11th, 2025 | 2022 | Jeremy Bender Chief Executive Officer and President | 610,000 | 0 | 812,820 | 290,000 | 12,200 | 5,086,456 |
| Friday, April 11th, 2025 | 2024 | Charles N. York II Chief Operating Officer and Chief Financial Officer | 541,000 | 0 | 1,530,640 | 299,400 | 13,800 | 3,896,080 |
| Friday, April 11th, 2025 | 2023 | Charles N. York II Chief Operating Officer and Chief Financial Officer | 515,000 | 0 | 842,760 | 231,800 | 13,200 | 3,546,093 |
| Friday, April 11th, 2025 | 2022 | Charles N. York II Chief Operating Officer and Chief Financial Officer | 495,000 | 0 | 313,720 | 220,000 | 12,200 | 2,319,451 |
| Friday, April 11th, 2025 | 2024 | Samuel Blackman Co-Founder and Head of Research and Development | 527,000 | 0 | 1,400,680 | 291,700 | 13,800 | 3,614,904 |
| Friday, April 11th, 2025 | 2023 | Adam Dubow General Counsel, Chief Compliance Officer and Secretary | 425,000 | 0 | 655,840 | 170,000 | 13,200 | 2,773,253 |
| Friday, April 11th, 2025 | 2024 | Adam Dubow General Counsel, Chief Compliance Officer and Secretary | 455,000 | 0 | 851,960 | 223,900 | 13,800 | 2,385,614 |
| Friday, April 11th, 2025 | 2022 | Samuel Blackman Co-Founder and Head of Research and Development | 470,000 | 0 | 270,940 | 181,000 | 12,200 | 2,077,197 |
| Friday, April 11th, 2025 | 2023 | Samuel Blackman Co-Founder and Head of Research and Development | 500,000 | 0 | 538,430 | 227,300 | 13,200 | 2,485,392 |
| Friday, April 11th, 2025 | 2024 | Jeremy Bender Chief Executive Officer and President | 680,000 | 0 | 2,700,280 | 501,800 | 13,800 | 6,560,577 |
| Friday, April 5th, 2024 | 2023 | Samuel Blackman Co-Founder and Head of Research and Development | 500,000 | 0 | 538,430 | 227,300 | 13,200 | 2,485,392 |
| Friday, April 5th, 2024 | 2022 | Samuel Blackman Co-Founder and Head of Research and Development | 470,000 | 0 | 270,940 | 181,000 | 12,200 | 2,077,197 |
| Friday, April 5th, 2024 | 2021 | Samuel Blackman Co-Founder and Head of Research and Development | 422,568 | 0 | 493,000 | 205,000 | 0 | 2,935,890 |
| Friday, April 5th, 2024 | 2023 | Adam Dubow General Counsel and Chief Compliance Officer | 425,000 | 0 | 655,480 | 170,000 | 13,200 | 2,773,253 |
| Friday, April 5th, 2024 | 2021 | Charles N. York II Chief Operating Officer, Chief Financial Officer and Secretary | 396,042 | 100,000 | 2,534,266 | 218,300 | 0 | 7,918,840 |
| Friday, April 5th, 2024 | 2023 | Jeremy Bender Chief Executive Officer and President | 647,000 | 0 | 1,779,160 | 388,200 | 13,200 | 6,913,959 |
| Friday, April 5th, 2024 | 2022 | Jeremy Bender Chief Executive Officer and President | 610,000 | 0 | 812,820 | 290,000 | 12,200 | 5,086,456 |
| Friday, April 5th, 2024 | 2021 | Jeremy Bender Chief Executive Officer and President | 523,021 | 0 | 5,168,061 | 313,800 | 0 | 19,761,110 |
| Friday, April 5th, 2024 | 2023 | Charles N. York II Chief Operating Officer, Chief Financial Officer and Secretary | 515,000 | 0 | 842,760 | 231,800 | 13,200 | 3,546,093 |
| Friday, April 5th, 2024 | 2022 | Charles N. York II Chief Operating Officer, Chief Financial Officer and Secretary | 495,000 | 0 | 313,720 | 220,000 | 12,200 | 2,319,451 |
| Friday, April 28th, 2023 | 2022 | Jeremy Bender Chief Executive Officer and President | 610,000 | 0 | 812,820 | 290,000 | 0 | 5,074,256 |
| Friday, April 28th, 2023 | 2021 | Jeremy Bender Chief Executive Officer and President | 523,021 | 0 | 5,168,061 | 313,800 | 0 | 19,761,110 |
| Friday, April 28th, 2023 | 2022 | Charles York II Chief Operating Officer and Chief Financial Officer | 495,000 | 0 | 313,720 | 220,000 | 0 | 2,307,251 |
| Friday, April 28th, 2023 | 2021 | Charles York II Chief Operating Officer and Chief Financial Officer | 396,042 | 100,000 | 2,534,266 | 218,300 | 0 | 7,918,840 |
| Friday, April 28th, 2023 | 2022 | Samuel Blackman Co-Founder and Chief Medical Officer | 470,000 | 0 | 270,940 | 181,000 | 0 | 2,064,997 |
| Friday, April 28th, 2023 | 2021 | Samuel Blackman Co-Founder and Chief Medical Officer | 422,568 | 0 | 493,000 | 205,000 | 0 | 2,935,890 |
| Thursday, April 28th, 2022 | 2020 | Samuel Blackman Co-Founder and Chief Medical Officer | 367,000 | 0 | 0 | 110,100 | 0 | 477,100 |
| Thursday, April 28th, 2022 | 2021 | Samuel Blackman Co-Founder and Chief Medical Officer | 422,568 | 0 | 493,000 | 205,000 | 0 | 2,935,891 |
| Thursday, April 28th, 2022 | 2021 | Charles York II Chief Operating Officer and Chief Financial Officer | 396,042 | 100,000 | 2,534,266 | 218,300 | 0 | 7,918,839 |
| Thursday, April 28th, 2022 | 2020 | Jeremy Bender Chief Executive Officer and President | 141,667 | 0 | 2,555,158 | 56,356 | 0 | 2,753,181 |
| Thursday, April 28th, 2022 | 2021 | Jeremy Bender Chief Executive Officer and President | 523,021 | 0 | 5,168,061 | 313,800 | 0 | 19,761,109 |
